ST Shuang Cheng: Injection-grade Bortezomib ANDA has obtained FDA approval for listing in the United States.

ST Shuangcheng Announcement: Recently received a notification from the Food and Drug Administration of the United States. The abbreviated new drug application for injectable bortezomib submitted by the company to the FDA has been approved.